Viridian Therapeutics, Inc.\DE (VRDN) insider trading.
In Q3 2026, insiders at Viridian Therapeutics, Inc.\DE reported 4 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $348K.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Net shares, P minus S
- -14,212
- Insiders
- 2
- Last filed
- 2026-08-20
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Tousignant Jennifer | Officer · Chief Legal Officer | 3 | 0 | 2 |
| Tripuraneni Radhika | Officer · Chief Medical Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-19 | Tousignant Jennifer | S (D) | 10,000 | $24.5 | 0 | Form 4 |
| 2026-08-19 | Tousignant Jennifer | M (A) | 10,000 | $14.41 | 10,000 | Form 4 |
| 2026-08-19 | Tousignant Jennifer | S (D) | 4,212 | $24.5 | 0 | Form 4 |
| 2026-08-14 | Tripuraneni Radhika | M (A) | 40,000 | $13.21 | 40,000 | Form 4 |
Transaction codes in this quarter
Get VRDN insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1590750&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · VRDN company page · Viridian Therapeutics, Inc.\DE on SEC.gov
Questions
Are insiders buying or selling Viridian Therapeutics, Inc.\DE (VRDN)?
In Q3 2026, insiders at Viridian Therapeutics, Inc.\DE reported 4 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $348K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Viridian Therapeutics, Inc.\DE insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/vrdn.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.